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As cost-containment pressures continue to escalate undergoing routine, elective coronary artery bypass 
in the health care industry, the cost-effectiveness of grafting. In the first group, fiberoptic catheters were 
new technologies must be verified if their use in the not used, whereas these catheters were used rou- 
care of patients is to be justified. Oximetrix fiberop- tinely in the second group. Multiple variables were 
tic pulmonary artery catheters (Abbott Critical Care analyzed in each group in an attempt to document 
Systems, North Chicago, IL) are used for the continu- cost-effectiveness or salutary effect on outcome as a 
ous measurement of mixed venous oxygen satura- result of the use of these catheters. Neither could be 
tion, and have been promoted as a cost-effective, confirmed. It was concluded that the use of Oxime- 
early, and accurate indicator of hemodynamic trix pulmonary artery catheters is not cost-effective 
changes in critically ill patients and patients and had no effect on outcome in this group of 
undergoing major surgical procedures. This retro- patients. 
spective study analyzed two groups of patients @ 1989 by W.8. Saunders Company. 
T HE CONTINUOUS measurement of mixed venous oxygen saturation (SVO,) by 
means of an Oximetrix pulmonary artery cathe- 
ter (Abbott Critical Care Systems, North Chica- 
go, IL) has been claimed to be an early, accurate, 
instantaneous, and cost-effective indicator of 
hemodynamic changes in critically ill patients.lW3 
Differing opinions have been expressed regard- 
ing both the cost-effectiveness and usefulness of 
these catheters for the measurement of SS02 in 
various classes of patients.‘s3 Cost-containment 
pressures exerted upon hospitals and their medi- 
cal staffs have been increasing for several years. 
Despite these pressures, costs continue to rise due 
to inflation, as well as to the introduction of new 
technologies such as the Oximetrix pulmonary 
artery catheter. 
have been routinely placed preoperatively in all 
patients undergoing elective coronary artery 
bypass grafting. 
The cost of the Oximetrix pulmonary 
artery catheter purchased at the authors’ institu- 
tion is approximately four times that of a conven- 
tional pulmonary artery catheter. Since August 
1985, Oximetrix pulmonary artery catheters 
The purpose of this retrospective study was 
to determine the cost-effectiveness and possible 
alterations in postoperative care of coronary 
artery bypass graft patients following the intro- 
duction of pulmonary artery catheters with con- 
tinuous measurement of SVO,. The cost-effec- 
tiveness of these catheters was evaluated by 
searching for a decrease in the various length- 
of-stay parameters measured, or for a decrease in 
the number of postoperative days of mechanical 
ventilation or postoperative cardiac outputs per- 
formed in the group in which SVO, was moni- 
tored. The effects of continuous SV02 monitoring 
on hospital morbidity were evaluated by analysis 
of the length of the various postoperative stay 
parameters. Rates of mortality were also exam- 
ined in these groups of patients during compara- 
ble periods before and after Oximetrix catheters 
were routinely used. 
MATERIALS AND METHODS 
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The charts of 41 patients undergoing coronary artery 
bypass grafting by a single surgeon during the months of 
March and April, 1985 (group l), and the charts of 46 
patients undergoing the same procedure by the same surgeon 
during the same months in 1987 (group 2) were reviewed 
retrospectively. A retrospective methodology was the neces- 
sary mode of evaluation of the cost-effectiveness of this 
particular technological advance for two reasons. First, a 
restrospective audit ensured that no bias could be introduced 
into the study by knowledge on the part of physicians and 
other care providers that a study (particularly one that 
examined treatment and treatment decision-making) was 
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Table 1. Variables That Indicate No Difference Between Groups 
Variable 1985 (Group 1) 1987 PSroup 2) P 
Total hospital days 15.8 k 3.5 13.2 + 2.3 0.28 
Postoperative hospital days 12.5 + 2.6 11.5 + 2.2 0.65 
Preoperative A8Gs 1.24 k 0.6 0.28 + 0.4 0.18 
Postoperative A8Gs 27.7 f 17.2 28.9 f 11.8 0.88 
Days of postoperative mechanical ventilation 4.0 * 1.0 3.5 + 0.8 0.69 
Postoperative intensive care days 6.8 f 1.9 5.6 + 0.7 0.42 
being conducted. Second, the surgeon involved felt so 
strongly that this monitoring technique was valuable that he 
opposed a randomized prospective study that would allocate 
patients into a group that would be denied, by any method, 
this form of monitoring. 
The months of March and April of each year were 
chosen for study to assure that the house staff caring for these 
patients in the thoracic intensive care unit (ICU) would have 
a relatively high level of training and would not be new to 
either the institution or their training program. The same 
period in each year was chosen to assure that similar levels of 
training existed in the surgical house staff caring for the 
patients being studied. Patients operated upon by a single 
surgeon were chosen to eliminate the possibility that attitudes 
of the surgeon in charge might bias results. No protocol 
existed in the ICU governing the response to changes in 
measured SvOo,. Decisions regarding these responses were 
solely at the discretion of the house officer on duty in the 
unit. 
Variables were chosen for analysis in an attempt to 
highlight cost savings in the second group of patients, which 
might have been the result of monitoring of Sv02 through the 
use of Oximetrix pulmonary artery catheters. The relative 
acuity of the two groups of patients and the differences in 
morbidity and mortality between these groups were also 
noted. Values for the following variables were determined for 
each patient: (I) total days of hospitalization, (2) total days 
of preoperative hospitalization, (3) total days of postoperative 
hospitalization, (4) number of preoperative arterial blood gas 
(ABC) determinations, (5) number of postoperative ABC 
determinations, (6) number of days of postoperative mechan- 
ical ventilation, (7) number of preoperative days spent in the 
ICU, (8) number of cardiac output determinations per- 
formed postoperatively, and (9) number of postoperative 
days spent in the ICU. Additionally, morbidity and mortality 
during the hospitalization were recorded for each group. 
The mean value *SD for each variable was deter- 
mined for each group. Comparisons between groups were 
then made for each variable using the Student’s t-test. 
Differences between the two groups were considered signifi- 
cant if P C 0.05. 
RESULTS 
Data presented in Table 1 demonstrate no 
statistically significant difference between the 
two groups in the total number of hospital days, 
total number of postoperative hospital days, total 
number of preoperative ABG determinations, 
total number of postoperative ABG determina- 
tions, total number of days of postoperative 
mechanical ventilation, and total number of post- 
operative days spent in the ICU. In addition, no 
difference in the in-hospital morbidity or mortal- 
ity rate was noted. 
Group 1 had significantly longer preopera- 
tive hospitalizations (P < 0.01) and. a greater 
number of preoperative days spent in the ICU 
(P < 0.007). Group 2 had a greater number of 
postoperative cardiac output determinations 
(P < 0.02). Table 2 presents 
variables in which statistical 
noted. 
the data for the 
significance was 
DISCUSSION 
Hospitals, doctors, and the health care 
industry in general are presently caught in an 
ever more stringent cost-containment environ- 
ment. As a result, technological advances in 
medical care can no longer be accepted for 
general use without convincing evidence of their 
cost-effectiveness, as well as their efficacy and 
safety. Cost-containment pressures are increas- 
ing from the federal sector as well as from private 
third-party payers. The proliferation of health 
maintenance organizations, preferred provider 
organizations, and other prepaid medical plans 
Table 2. Variables That Indicate Differences Between Groups 
Variable 1985 (Grouo 1) 1987 (Grouo 2) P 
Days of preoperative hospitalization 3.3 * 0.4 1.7 + 0.1 0.01 
Preoperative intensive care days 1.37 f 0.2 0.11 * 0.1 0.007 
Postoperative cardiac output determinations 4.0 f 3.6 13.9 k 10.0 0.02 
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has likewise increased the pressure for economy. 
Examples of governmental pressures applied to 
control the cost of medical care include regula- 
tions promulgated by the Health Care Financing 
Administration (HCFA) in implementing sec- 
tion 9-52 of the Omnibus Reconciliation Act of 
1980.4 Section 127 of the Tax Equity and Finan- 
cial Responsibility Act of 1982 (TEFRA)5 
applied these regulations retroactively to Decem- 
ber 1980. In addition, the advent of the concept 
of diagnosis-related groups (DRGs) has further 
increased the pressures on hospitals, medical 
staff members, and others involved in the care of 
patients to reduce costs. When costs are not 
controlled, hospitals may be left liable for the 
difference between their actual costs and the 
established payment rate for any particular diag- 
nosis. In this environment it becomes important 
to substantiate the cost-effectiveness of any new 
technology used in the care of patients. This is 
particularly true when the new technology costs 
more per patient to use, as is most often the 
case. 
The lack of difference between the two 
groups regarding the variables displayed in 
Table 1 indicates that the overall level of acuity 
for the two groups of patients was comparable. 
The significantly longer preoperative hospital- 
izations and longer preoperative ICU stays of 
patients in group 1 may be interpreted as an 
indication of higher patient acuity in this group. 
However, it is thought that the lack of significant 
differences in other variables more specific for 
high patient acuity, such as total hospital days, 
total postoperative hospital days, total postopera- 
tive ICU days, total days of postoperative 
mechanical ventilation, and in-hospital mortality 
rates, more strongly supports the contention that 
the groups are comparable. The shorter preoper- 
ative hospitalization and preoperative ICU stay 
of group 2 patients is more likely the result of an 
increased demand for cost containment by 
decreasing resource utilization, ie, shorter hospi- 
tal stays, in 1987. 
The greater number of postoperative car- 
diac output determinations in group 2 may have 
been the result of continuous monitoring of SVOZ. 
Minute-to-minute changes in this value may 
have suggested to house staff physicians that 
changes in the patient’s clinical status had 
occurred that warranted further investigation by 
cardiac output determination. No protocol exist- 
ed in the ICU governing the response to changes 
in measured SVO,. Due to a paucity of written 
information in patient charts, it was not possible, 
in this retrospective study, to determine clear 
indications for ordering cardiac output determi- 
nations or what changes in therapy, if any, were 
based on either the change in SVO, or the cardiac 
output. During March and April of 1985, cardiac 
output determinations in the ICU required that 
the respiratory therapy department be sum- 
moned to perform these tests; whereas during the 
1987 period, these determinations were per- 
formed by the nursing staff in the ICU. There- 
fore, the greater number of postoperative cardiac 
output determinations may simply be a reflection 
of greater availability. Another consideration 
may be that the reported lack of correlation 
between SV02 and cardiac output6y7 led the house 
staff to obtain a greater number of cardiac 
output determinations. Changes in SVOZ may be 
brought about by changes in cardiac output, 
hemoglobin concentration, oxygen delivery, and 
oxygen consumption.8 This requires that a 
change in 50, be evaluated to determine its 
etiology. Usually, this means obtaining the value 
of the cardiac output and other parameters of 
hemodynamic function.g Of interest is a similar 
increase in the number of cardiac output deter- 
minations reported by Pearson et al (personal 
communication, January 1988) in their study of 
the cost-effectiveness of Oximetrix pulmonary 
artery catheters in the treatment of patients 
following all types of open heart surgery. They 
attributed this increase in the number of cardiac 
output determinations in their study to possible 
overemphasis on the importance of monitored 
changes in SVO,. 
It could be argued that the greater number 
of cardiac output determinations performed in 
group 2 reflected a superior level of care that was 
much more attuned to minute-to-minute varia- 
tions in patient condition. Mitigating against this 
argument is the lack of difference in those 
parameters listed in Table 1. A superior level of 
patient care would be expected to resdlt in 
shorter ICU and hospital stays, shorter periods of 
mechanical ventilation, fewer ABG determina- 
tions, and improved mortality in group 2. There 
is also no indication that the fewer number of 
preoperative hospital and KU days in group 2 
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were linked to the use of the fiberoptic pulmo- 
nary artery catheter. Forty-three out of 46, or 
93.5%, of these catheters were placed as a routine 
measure immediately before surgery and were 
not used preoperatively in the ICU. 
This study provides no evidence that the 
use of Oximetrix pulmonary artery catheters for 
the measurement of SS02 in the population stud- 
ied has any cost-containment influence. In fact, 
the study suggests that the postoperative mea- 
surement of SV02 may increase the cost of care in 
this group by requiring more frequent cardiac 
output determinations during the postoperative 
period. The increased annual cost of routine use 
of Oximetrix pulmonary artery catheters in coro- 
nary artery bypass graft patients in the study 
institution is approximately $71,500 on a pro- 
jected annual caseload of 550. The cost of the 
increased number of cardiac output determina- 
tions in the 1987 group cannot be calculated 
because their cost was included in the basic daily 
intensive care charge. This daily charge was 
$114 greater in the 1987 group, but no mecha- 
nism exists in the institution to separate the 
portion of this charge attributable to cardiac 
outputs. This study does not directly address the 
issue of increased quality of care given patients 
as a result of utilization of Oximetrix pulmonary 
artery catheters to constantly measure SV02. 
Indirect evidence that the quality of care in this 
group was not significantly improved is demon- 
strated by the lack of difference in postoperative 
hospital days, postoperative ABG determina- 
tions, days spent on mechanical ventilation post- 
operatively, and overall mortality. It would 
appear, based on the data, that the increased 
expense incurred by the use of Oximetrix pulmo- 
nary artery catheters for the continuous mea- 
surement of SV02 in patients undergoing elective 
coronary artery bypass grafting cannot be justi- 
fied. 
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